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Runx2/Cbfa1 plays a central role in skeletal development as demonstrated by the absence of osteoblasts/bone in mice with
inactivated Runx2/Cbfa1 alleles. To further investigate the role of Runx2 in cartilage differentiation and to assess the
potential of Runx2 to induce bone formation, we cloned chicken Runx2 and overexpressed it in chick embryos using a
retroviral system. Infected chick wings showed multiple phenotypes consisting of (1) joint fusions, (2) expansion of carpal
elements, and (3) shortening of skeletal elements. In contrast, bone formation was not affected. To investigate the function
of Runx2/Cbfa1 during cartilage development, we have generated transgenic mice that express a dominant negative form of
Runx2 in cartilage. The selective inactivation of Runx2 in chondrocytes results in a severe shortening of the limbs due to
a disturbance in chondrocyte differentiation, vascular invasion, osteoclast differentiation, and periosteal bone formation.
Analysis of the growth plates in transgenic mice and in chick limbs shows that Runx2 is a positive regulator of chondrocyte
differentiation and vascular invasion. The results further indicate that Runx2 promotes chondrogenesis either by
maintaining or by initiating early chondrocyte differentiation. Furthermore, Runx2 is essential but not sufficient to induce
osteoblast differentiation. To analyze the role of runx genes in skeletal development, we performed in situ hybridization
with Runx2- and Runx3-specific probes. Both genes were coexpressed in cartilaginous condensations, indicating a
cooperative role in the regulation of early chondrocyte differentiation and thus explaining the expansion/maintenance of
cartilage in the carpus and joints of infected chick limbs. © 2002 Elsevier Science (USA)
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Skeletal development begins with the migration of cells
to the site of future skeletogenesis according to a geneti-
cally determined pattern. Through a series of cellular inter-
actions, condensations are formed, a pivotal step in skeletal
development. Such condensations represent the outline of
the future skeleton, but patterning within one condensa-
tion can be quite complex with more than one bone arising
from a single condensation. Major elements of the limb
skeleton, for example, arise from a single condensation that
later gets subdivided into individual skeletal elements
connected by joints. After the initial step of condensation,
cells differentiate into either chondrocytes surrounded by a
layer of flattened cells, the perichondrium, or bone-forming
osteoblasts. In areas of endochondral ossification, a carti-
laginous template of the future skeleton is formed first. As
a next step, chondrocytes in the middle of the cartilaginous
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All rights reserved.anlage differentiate and become hypertrophic. Finally, their
matrix calcifies. In parallel to the process of hypertrophic
differentiation, newly differentiated osteoblasts deposit a
thin layer of cortical bone around the central part of the
anlage. The calcified matrix of the hypertrophic chondro-
cytes is degraded by matrix metalloproteinases that are
secreted by the hypertrophic chondrocytes themselves and
by osteoclasts that invade through the bone collar. This
process attracts blood vessels to invade the primary ossifi-
cation center via the periosteal bone shaft. With the invad-
ing blood vessels, osteoblasts and hematopoietic stem cells
reach the center of the cartilage anlage. Osteoblasts produce
bone matrix and are responsible for the maintenance of
bone density and strength. Osteoclasts are highly special-
ized cells that remove cartilage and bone matrix. Growth,
homeostasis, and regeneration evolve, in principle, around
these mechanisms. Central to normal growth is the regula-
tion of chondrocyte proliferation and differentiation. To
guarantee proper bone development, the condensation and
differentiation of cartilage, its removal by osteoclasts, and
the formation of new bone by osteoblasts have to be tightly
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FIG. 1. (A) Expression of Runx2 and Runx3 in mouse embryos using whole-mount in situ hybridization with specific digoxygenin-labeled
riboprobes. At E10.5, Runx2 is expressed in a region anterior of the limb bud, corresponding to the future shoulder girdle region and in some
cells of the first and second branchial arches. At E11.5 and E12.5, expression of Runx2 becomes very prominent in the developing mandible
and in condensations of other facial bones. Runx3 is not expressed at these sites. (B) Expression of Runx2 and Runx3 in mouse limb buds.
At E11.5, Runx2 but not Runx3 is expressed in the anlagen of the humerus and the shoulder girdle. Overlapping expression patterns of
Runx2 and Runx3 are found in the condensing mesenchyme of the future ulna (arrows). By E12.5, this expression has become stronger and
is now also present in the radius. By E13.5, we find expression of both genes in the proximal part of the metacarpals, the proximal phalanges,
and the distal phalanges. (C) Section in situ hybridization with a 33P-labeled antisense probe showing expression of Runx3 in dorsal root
ganglia (left, arrow) and the trigeminal ganglion (right, arrow). (D) Runx3 is expressed in Runx2/ mice. Section through a Runx2/ limb
at E14.5 showing strong expression of Runx3.
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FIG. 2. (A) Section in situ hybridization with 33P-labeled antisense riboprobes specific for Runx2 (top panel) and Runx3 (bottom panel).
Expression in the mouse autopod at E13.5. Note nearly identical expression patterns of Runx2 and Runx3 with strong expression in the
perichondrium and to a lesser degree within chondrocytes of the metacarpal anlagen (m), the proximal phalanges (p), and in a region
corresponding to the future distal phalanges/claws. Both genes are not expressed in the future joint region (arrow) and the carpal bones (c).
The expression pattern of Gdf5 (top) and collagen type II (Col2a1) is given for comparison on the right side. (B) Sections through humeri of
stages E14.5 and E15.5 hybridized with specific probes for Runx2 and Runx3. The corresponding bright light images are given on the left
side. The area of hypertrophic chondrocytes is indicated (*). Note strong expression of Runx2 in the perichondrium (arrows), in osteoblasts,
and in hypertrophic chondrocytes. In contrast, Runx3 is expressed in prehypertrohic chondrocytes and to a lesser degree in the
perichondrium. At E15.5, we find weak expression in the bone marrow cavity (bc). Note absence of Runx3 expression in hypertrophic
chondrocytes. To identify specific cells and expression domains, the expression patterns of collagen type I (Col1a1) and collagen type X
(Col10a1) are shown in the right panel. Col1a1 is expressed in the perichondrium and in osteoblasts but not in chondrocytes. Col10a1 is
expressed in hypertrophic chondrocytes. Runx2 and Runx3 are not expressed in the joint region (future elbow joint indicated by arrows)
(bottom panel).
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coordinated. Any disturbance of these processes invariably
results in reduced growth rates and shorter bones. The
molecular mechanisms controlling skeletal growth, devel-
opment, and homeostasis are slowly emerging and several
essential factors have been identified (for review, see
McLean and Olsen, 2001; Hall and Miyake, 2000).
In previous studies, Runx2/Cbfa1 was identified as a
major regulator of bone development (Komori, 2000;
Karsenty, 2000). This gene belongs to a small family of
transcription factors (consisting of Runx1, Runx2, and
Runx3) that show strong homology to the Drosophila gene
runt. RUNX1, originally termed AML1, was identified
through its involvement in leukemia-associated transloca-
tions. The inactivation of Runx1 in mice results in a block
in fetal liver hematopoiesis, indicating a central role for this
gene in the differentiation of myeloid and erythroid pro-
genitor cells (Okuda et al., 1996). In contrast, mutations in
RUNX2/CBFA1 are responsible for the skeletal malforma-
tion syndrome cleidocranial dysplasia (CCD), a syndrome
characterized by multiple skeletal abnormalities, including
persistently open fontanelles, absent/hypoplastic clavicles,
supernumerary teeth, short stature, and multiple other
minor changes in skeletal growth and development (Mund-
los et al., 1997; Quack et al., 1999). The function of
Runx3/Cbfa3 is unknown.
Mouse models have enhanced our understanding of the
basic functions of Runx2. Heterozygous inactivation of the
gene results in a phenotype that is very similar to human
CCD (Mundlos et al., 1996; Huang et al., 1997; Otto et al.,
1997). The homozygous inactivation of Runx2 results in a
complete loss of bone (Otto et al., 1997; Komori et al.,
1997). These mice die shortly after birth due to respiratory
insufficiency. Runx2/ mice show a block in osteoblast
differentiation and lack expression of osteoblast-specific
genes such as osteocalcin. Runx2 is thus essential for
osteoblast differentiation. More detailed investigation of
the mouse phenotype revealed, in addition to a defect in
osteoblast differentiation, abnormal differentiation of chon-
drocytes (Kim et al., 1999; Inada et al., 1999). In Runx2/
mice, chondrocytes do not develop toward hypertrophy or
are very delayed in doing so. This may be due to a lack of
signals from the bone collar or the perichondrium. How-
ever, Runx2 was shown to be expressed in prehypertrophic
and hypertrophic chondrocytes, indicating that Runx2 may
have a role during differentiation of cartilage as well. In
contrast to Runx1 and Runx2, the role of Runx3 during
embryonic development has not been investigated yet.
To further investigate the possible role of runx genes in
cartilage development and to test for the capacity of Runx2
to induce bone formation, we performed a series of experi-
ments using overexpression of Runx2 in chick embryos as
well as selective inhibition of runx function in mice. In
addition, we performed a detailed expression analysis of
Runx2 and Runx3 during development. Our results demon-
strate an important role of Runx genes in cartilage develop-
ment in the regulation of early as well as late differentiation
of chondrocytes, and they show that Runx2, albeit essen-
tial, is not sufficient for bone formation.
METHODS
Histology and Staining
Limbs were fixed overnight in 4% PFA in PBS and embedded in
paraffin or historesin (Leica). Embedded limbs were sectioned to 7.5
m (paraffin) and 2.5 m (historesin) and stained with hematoxilin/
eosin (H&E), Toluidine Blue, or van Kossa staining (Mundlos,
2000). For skeletal preparations, the embryos were skinned and
eviscerated, and fixed overnight in ethanol. Alcian blue/alizarin red
staining was performed as previously described (Mundlos, 2000).
Staining for tartrate resistant acid phosphatase (TRAP) was per-
formed by using the Leukocyte Acid Phosphatase Kit (Sigma)
according to the manufacturer’s recommendations.
In Situ Hybridization
In situ hybridization was performed by using [33P]UTP-labeled
antisense probes. The following probes were used for in situ
hybridization on mouse tissues: collagen type II (Col2a1), collagen
type X (Col10a1), collagen type I (Col1a1), and osteopontin (Osp)
(Mundlos, 2000; Kim et al., 1999), PTHrP-Receptor, Ptc, Ihh,
(Vortkamp et al., 1996). Probes for MMP9 (Reponen et al., 1994)
and MMP13 (Henriet et al., 1992) were generated by RT-PCR with
Primers MMP9F: GGGAAGGCTCTGCTGTTCAGC, MMP9R:
TCTAGAGACTTGCACTGCACG, and MMP13F: CATTCAGT-
CATCCTGGCCACCTTC, and MMP13R: CATCCACATGGTT-
GGGAAGTTCTG, respectively. Special care was taken to design
specific probes for Runx2 and Runx3 since both genes are highly
homologous. To avoid cross-hybridization, probes were generated
from the 3 untranslated regions that showed no significant homol-
ogy to other genes. The probe for Runx2 was generated by using
primers F: GTGTTCTGTGGTCTCTGAG and R: GGCAAAAGC-
TTGCAGAACTC, the probe for Runx3 with primers F: CTACTA-
AGCACCCTGGACAC and R: GAAAGTCCAGACATCTCTG-
AG. In addition, we used a probe generated from the runt domain-
encoding region of Runx2 which, due to the high similarity, is able
to cover all runt-related genes.
For in situ hybridization on chicken tissue, the following probes
were used: chIhh (Vortkamp et al., 1996), chGdf5 (Hartmann and
Tabin, 2001), and chSox9 (Healy et al., 1996).
Whole-mount in situ hybridization was performed as previously
described (Nacke et al., 2000). Embryos were exposed to NBT/BCIP
detection solution until appearance of background staining in order
to trace small sources of expression.
Retroviral Injections
Construct design. We initially used mouse Runx2 for our
retroviral injection experiments. Mouse Runx2 was generated from
two overlapping fragments amplified by RT-PCR by using the
primers F: GACCATGGCGTCAAACAGCCTCTTC and R: CTC-
CACCATGGTGCGGTTGTC. This fragment was cloned into the
NcoI site of pSlax13. (3-Fragment primers: F: CAGCAGCCTG-
CAGCCCGGCCAAG, R: TACTGCAGGGCCATGGTTGACGA-
ATTTC.) Full-length mouse Runx2-cds was generated by inserting
the 3-fragment into the PstI sites in the 5-fragment and the
pSlax13-MCS (pSlax-mRunx2-II). Chicken Runx2 was cloned by
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RT-PCR from cDNA of 8-day-old chicken embryonic limbs. Two
overlapping fragments were generated with the primers: 5F: ATC-
CATGGCATCAAACAGCCTCTT, 5R: GGTCTTGTTGCAGC-
GCCA; 3F: AATATGGCCGCCAAACAGACTC, 3R: CACCGA-
CAGCCCCAACTTC. For the injection construct, the NcoI
fragment in pSlax-mRunx2-II was replaced by the corresponding
NcoI fragment from the 5 RT-PCR product. For both constructs,
the inserts were released with ClaI and inserted into the ClaI site
of the RCASBP(A)-Vector. Virus production was performed as
described by Morgan and Fekete (1996). Concentrated virus with a
titer of 6-8  108 pfu/ml was injected into the right wing field of
HH stage 10 chicken embryos (Hamburger and Hamilton, 1951).
The sequence obtained for the coding region of chicken Runx2 was
deposited in GenBank (Accession No. AF445419).
Generation of Transgenic Mice
The runt domain and the nuclear localization signal of Runx2
were amplified from mouse E16.5 cDNA by using the primers F:
ATCTTCTAGAGCCACCATGGTGGAGGATCATC; R: GTCG-
CTCGAGTCAGTCATCAAGCTTCTGGCT. The PCR product
was digested with XbaI and XhoI and cloned into pBluescript-SK
(pBl-runt). In this clone, the KpnI site within the runt-domain was
changed from GGTACC to GGTGCC by PCR-based mutagenesis.
The amino acid sequence remained unchanged (pBl-runt-KpnMut).
The runt domain was excised from pBl-runt-KpnMut with XbaI
and XhoI, blunted, and cloned into the unique EcoRV site within
exon 52 of a Collagen2a1-Promoter expression construct (Sakai et
al., 2001). The orientation and sequence integrity was confirmed by
double-strand sequencing. The construct was released by digestion
with NotI and KpnI. The fragment was purified by agarose gel
electrophoresis followed by gel extraction with Qiagen QuickPrep
columns. The purified fragment was diluted to approx. 2 pmol/l in
10 mM Tris/0.1 mM EDTA, pH 7.6, and injected into pronuclei of
fertilized B6C3F1 oocytes according to standard protocols (Hogan
et al., 1994). The injected oocytes were transferred into the ovi-
ducts of pseudopregnant CD1 females. The progeny was tested for
integration of the transgene by PCR using the Primers F: ACA-
GAGCTATTAAAGTGACAGTG; R: GGTTCGCAATGGATTG-
TGTTG. The mice were maintained on the mixed background and
crossed to homozygosity. Potential homozygous founder animals
were tested by breeding them with wt mice. The offspring derived
from two matings were analyzed for the transgene. Animals that
produced only offspring positive for the transgene were taken as
founder mice for the homozygous line.
BrdU Labeling
For BrdU incorporation, pregnant mice were injected intraperi-
toneally with 250 g BrdU (Boehringer) per gram of body weight.
The mice were sacrificed 8 h after injection and the embryos were
fixed overnight in 70% ethanol/50 mM Glycine, pH 2.0, and then
embedded in paraffin and sectioned to 7.5 m. BrdU-positive cells
were detected with the BrdU Labeling and Detection Kit II (Boehr-
inger) according to the manufacturer’s instructions.
RESULTS
Expression of Runx Genes in Development
We performed detailed in situ hybridizations using probes
specific for Runx2 and Runx3. All probes were generated
from 3 untranslated sequences showing minimal or no
homology to the other Runx genes. Specificity of the probes
was documented by their distinct expression patterns.
Whole-mount in situ hybridization with Runx2 and Runx3
probes revealed distinct expression domains for both genes
(Fig. 1). Runx2 was found to be expressed as early as E10.5
in a region anterior to the limb bud, corresponding to the
future shoulder girdle (Figs. 1A and 1B, top panels). With
further development, strong Runx2 expression was ob-
served in the first and second branchial arches in a region
corresponding to the future maxilla and mandible. We did
not observe these expression domains using the Runx3-
FIG. 3. Morphological and histological changes in chicken limbs induced by retroviral misexpression of chRunx2. (A) Alizarin red
(calcified elements) and Alcian blue (cartilage) staining of skeletal elements at day 8.5 (HH35) (left) and 11 (HH37) (right) of development.
Wing pair showing the normal skeletal pattern of the left uninjected wing (L) and the changes induced by overexpression of chRunx2 in the
right wing (R). Overexpression results in shortening of the bones. The relative size of the metacarpal and the ulna of the injected wing is
indicated by bars. Multiple joint fusions in the infected wing are indicated by arrows. (B) Retroviral misexpression results in joint fusions.
Skeletal preparation of digit II at stage HH37 showing fusion of the interphalangeal joints in the infected wing (R). A corresponding
H&E-stained section of a similarly affected wing is shown below. Preparation of a wt digit (L) is shown on left, interphalangeal joints are
indicated by arrows. Gdf5 is normally expressed in the joint interzone (arrow). No expression was detected in the affected joints, as shown
for the metacarpophalangeal joint of digit II (arrow). (C) Skeletal preparation of an infected wing at stage HH35 (right) with fusion between
the humerus and the radius/ulna (arrows). A wt joint is shown on the left side, the joint space is indicated by arrows. In the uninfected limb,
Sox9 is expressed in chondrocytes whereas no expression could be detected in the joint interzone. In the infected limb, a continuous high
expression of Sox9 was found. (D) Retroviral misexpression results in expansion and fusion of carpal elements. H&E-stained sections
through the carpal region of HH37 chick wings show expanded and fused carpal elements in the infected limb (indicated by *). The
phenotype correlates with the RCAS infection and high expression of chRunx2 as indicated by in situ hybridization with a probe against
the runt domain of Runx2 to infected (right) and uninfected (left) tissue. (E) Section through a digit III metacarpal of an uninfected (top, L)
and infected (bottom, R) wing. The bright light image shows the reduction in length of the infected metacarpal. In situ hybridization with
a probe specific for Ihh shows a smaller expression domain in the infected bone (indicated by white bar) and a smaller resting and
proliferative zone (indicated by black arrow). (F) Sections through a radius of an uninfected (L, top) and infected (R, bottom) wing stained
with van Kossa demonstrating normal bone formation but increased width (arrow) and larger zone of invasion (indicated by bars) in the
infected bone.
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specific probe. In the head, Runx3 was expressed at a
specific site anterior of the eye and in the developing
nostrils (Fig. 1A). In contrast to Runx2, Runx3 was ex-
pressed in the dorsal root and the trigeminal ganglia (Fig.
1C). At E11.5, both genes were coexpressed in the conden-
sation of the ulna, and at E12.5 also in the condensing
radius. At E13.5, both genes were coexpressed in the auto-
pod. Expression was detected in perichondrium of metacar-
pals and proximal phalanges and the condensations of the
distal phalanges (Figs. 1B and 2A). To test whether Runx3 is
regulated by Runx2, we analyzed Runx3 expression in
Runx2/ mice (Otto et al., 1997). We found normal expres-
sion of Runx3 (Fig. 1D).
Section in situ hybridization was performed to analyze
the expression of Runx2 and Runx3 during later stages of
skeletal development. Runx2 and Runx3 were found to be
coexpressed in the developing digits at E13.5 (Fig. 2A) and
E14.5 (not shown). Interestingly, the expression was con-
fined to perichondrium and the chondrocytes located in the
proximal part of the metacarpals and phalanges. The devel-
oping joint region (expressing Gdf5) and the adjacent distal
part of the metacarpals (expressing Col2a1) was spared.
There was no expression in the developing carpal bones
either (Fig. 2A). We used sections of E14.5 and E15.5 humeri
to assess expression during later stages of development (Fig.
2B). The identity of Runx-expressing cells was determined
by in situ hybridization with Col10a1 (expressed in hyper-
trophic chondrocytes) and Col1a1 (expressed in perichon-
drium and osteoblasts but not in chondrocytes). Runx2 was
strongly expressed in hypertrophic chondrocytes and in
periosteum/osteoblasts. In contrast, Runx3 was expressed
mainly in prehypertrophic chondrocytes. We also observed
some expression in the perichondrium. However, high
magnification showed that osteoblasts did not express
Runx3 (not shown). At E15.5, expression of Runx3 was
found in the bone marrow cavity. It was not possible to
localize the signal to a specific cell type (osteoblasts vs
hematopoietic cells). Expression of Runx2 and Runx3 was
not detectable in cartilage or perichondrium around the
future elbow joint at E14.5 (Fig. 2B, bottom panel).
Cloning of Chicken Runx2
To investigate Runx2 in the chick embryo, we cloned
chicken Runx2 using a PCR-based strategy. ChRunx2
shows an overall homology of 94% with mouse Runx2 and
a 95% homology with human RUNX2 on amino acid level.
The only major difference between chick and mouse Runx2
FIG. 4. (A) Generation of transgenic mice. Schematic representa-
tion of the construct used is shown at top. The runt domain of
Runx2 including the nuclear localization signal (nls) was cloned
into a chondrocyte specific 1 (II) collagen promotor/enhancer
cassette. The original ATG of the Col2a1 gene located in exon 1
(E1) was mutated (ATG3 ATC) and replaced by a start codon
directly 5 of the runt/nls insert. A digoxygenin-labeled riboprobe
against the runt domain showed strong expression in all chondro-
cytes with the exception of hypertrophic chondrocytes (shown on
left). For comparison, collagen type X (Col10a1) expression is
shown on right. (B) Skeletal phenotype of 1 (II)-runt mice. Alcian
blue/alizarin red-stained skeletons of E17.5 mice showing severe
shortening of limbs in 1 (II)-runt mice. The scapula is very small
-
and shows hardly any ossification. Likewise, there is no ossifica-
tion in the metacarpals or the phalanges. The vertebral bodies of
the tail have irregular shapes (arrow) resulting in tail kinks. H&E
histology (bottom) shows a severe delay in chondrocyte maturation
and bone formation (sections through a E15.5 humeri). bc, bone
marrow cavity and endochondral bone.
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is the length of the polyglutamine/polyalanine coding re-
peat in the N-terminal part of the protein. In mice, the
repeat encodes for 29 glutamines and 18 alanines. In the
chick, this repeat consists of only 12 glutamines and 2
alanines.
Expression of chRunx2 in Chicken Limbs
To analyze the effect of Runx2 overexpression in vivo, we
infected chicken limb buds with a retroviral system (RCAS)
expressing chRunx2. Preliminary experiments had shown
that the mouse Runx2 gene had no effect in the chick
system, a finding that may be due to the different length of
the polyglutamine/polyalanine repeat in the chick. We
harvested chick embryos at stages 25, 35, and 37. The
efficiency of infection was tested by RT-PCR and by whole-
mount and section in situ hybridization. In limbs with
strong RCAS/runt expression, we observed three major
phenotypes: (1) fusion of multiple joints, (2) enlargement of
carpal cartilaginous elements, and (3) shortening of long
bones, particularly of the distal elements (Fig. 3A). In the
infected limbs, joint fusions were observed to a variable
extent corresponding to the level of infection. The most
distal elements, i.e., the interphalangeal joints, were most
consistently affected. Histology of the fused joints revealed
a complete or partial absence of the characteristic joint
interzone, or, in later stages, of the joint space (Fig. 3B). The
space was filled with undifferentiated chondrocytes, similar
to earlier stages before segmentation had taken place.
Correspondingly, Gdf5, a marker for cells of the joint
interzone, was not expressed (Fig. 3B, bottom panel). Sox9
was expressed throughout the fused joint, indicating the
presence of chondrocytes (Fig. 3C). In the chick, the carpal
bones consist of a major radial and a small ulnar carpal.
Other small carpal bones appear but they subsequently fuse
with each other and the metacarpals to form the carpo-
metacarpus. In chRunx2-injected wings, we observed devel-
opment of one big carpal condensation extending from the
radial to the ulnar side that corresponds with a strong
RCAS-infection in this area (Fig. 3D). Infected long bones
were smaller in size and frequently showed a widening,
particularily at the ends (Figs. 3A, 3E, and 3F). Using in situ
hybridization with Indian hedgehog, a gene expressed in
prehypertrophic chondrocytes (Vortkamp et al., 1996), we
found a reduction in size of the proliferative zone as well as
a smaller prehypertrophic zone (Fig. 3E). H&E (not shown)
and van Kossa staining revealed relatively normal periosteal
bone formation (Fig. 3F). We did not detect ectopic bone
formation at highly infected sites outside the normal bone
pattern and we did not observe a difference in cortical bone
formation between infected and control limbs. However,
invasion of calcified cartilage by blood vessels was ad-
vanced in infected limb bones (Fig. 3F).
Generation of 1(II)-Runt Mice
To investigate the role of Runx2 in chondrocyte differen-
tiation independent of its function in osteoblast differentia-
tion, we selectively inhibited Runx2 function in the growth
plate by using a truncated Runx2 construct expressing only
the DNA-binding (runt) domain and the nuclear localiza-
tion signal under the Col2a1 promotor (Fig. 4A). This
construct is supposed to act in a dominant negative manner
since it lacks the transactivation domains of Runx2 but is
still capable to translocate into the nucleus (Qack et al.,
2000) and to bind its target sequence (Thirunavukkarasu et
al., 1998). Three transgenic lines were obtained. Expression
of the transgene was demonstrated with RT-PCR (not
shown) and in situ hybridization. Expression of the trans-
gene was detected in the entire cartilage element, with the
exception of the hypertrophic zone which expresses colla-
gen type X (Col10a1) (Fig. 4A). This is the expected expres-
sion pattern of Col2a1 (Mundlos, 1994). The line with the
strongest expression [called “1(II)-runt” mice thereafter]
was crossed to homozygosity and used for all further
investigations.
Phenotype of 1(II)-Runt Mice
Transgenic mice expressing the 1(II)-runt construct
were viable and showed normal breeding behaviour. Af-
fected mice are characterized by their smaller body size, a
short snout, and kinky tails. Alizarin red- and Alcian
blue-stained skeletons demonstrated, in contrast to
Runx2/ mice, a normal ossification of the skull vault. The
cartilaginous part of the skull, however, showed a short-
ened nasal cartilage and abnormalities of the skull base
(data not shown). Ossification of the vertebrae was delayed
and some vertebrae showed an abnormal shape leading to
the “kindly tail” phenotype. The most pronounced pheno-
type, however, was observed in the bones of the limbs (Fig.
4B). There was a severe delay in ossification resulting in the
absence of bone at E15.5, a stage when all long bones show
large ossification centers in wt mice. Histology showed a
small hypertrophic zone and a delay in periosteal bone
formation (Fig. 4B, bottom panel). By E17.5, bone formation
had occurred but the resulting bony diaphysis in the hu-
merus was only one-third of the size of the wt. The scapula
showed a severe ossification defect and was only half the
size of the wt bone. Radius and ulna were affected in a
similar manner, but less severely. Ossification centers were
absent in the digits. Van Kossa staining demonstrated a lack
of ossification in the humerus at E15.5, a time when wt
specimens showed strong endochondral and periosteal
ossification/bone formation (Fig. 5, top panel).
Chondrocyte Differentiation in 1(II)-Runt Mice
To investigate the defect in 1(II)-runt mice in more
detail, we performed in situ hybridization with probes
specific for chondrocyte differentiation on humeri of wt and
mutant animals at different embryonic stages (Fig. 5).
Indian hedgehog (Ihh) is expressed in prehypertrophic and
hypertrophic chondrocytes overlapping with Collagen type
X (Col10a1), which is expressed in hypertrophic chondro-
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cytes only. Ihh and Col10a1 are initially expressed as a
single band in the middle of the cartilage anlage (E13.5 for
Ihh and E14.5 for Col10a1). Their expression domain is
subsequently divided into two domains that flank the
newly formed bone on each side. Osteopontin (Osp) is
expressed in late hypertrophic chondrocytes at the
cartilage/bone junction and in osteoblasts. MMP13 (Colla-
genase III) is a metalloproteinase involved in matrix remod-
eling. Expression sites are late hypertrophic chondrocytes
and osteoblasts. MMP9 (Gelatinase B) is expressed in oste-
oclasts. Staining for tartrate resistant acidic phophatase
(TRAP) was used to visualize osteoclasts.
At E14.5, a large hypertrophic zone has formed in wt
humeri and vascular invasion of hypertrophic cartilage is
beginning. The Col10a1-expressing hypertrophic zone is
flanked on both sides by a band of cells expressing Ihh. In
the mutant, we found no Col10a1 expression and only a
continuous zone of weak Ihh expression, indicating that
chondrocytes had not entered hypertrophy yet. By E15.5, a
single band of Col10a1-expressing cells was found in the
mutant, when in the wt, the zone had split into two
domains. The hypertrophic cells in the mutant, however,
had not reached teminal differentiation yet, as demon-
strated by the lack of Osp expression. Osp expression was
found in only a few cells in the developing bone collar,
indicating that not only chondrocyte differentiation, but
also periosteal bone formation was disturbed. In the wt
terminal hypertrophic chondrocytes, the periosteum and
the osteoblasts forming the trabecular bone showed strong
Osp expression. The same was true for the expression of
MMP13 that was virtually absent from E15.5 humeri. The
expression at E16.5 was comparable to wt expression at
stage E14.5 (not shown). At E15.5, we found abundant
osteoclasts in wt specimens in the endochondral bone and
in particular at the cartilage/bone junction as demonstrated
by staining for TRAP. In transgenic mice, there were only a
few positively stained cells in the perichondrium at E15.5,
and by E16.5, some degree of invasion from the periosteum
was observed. MMP9 is normally expressed in the mesen-
chyme surrounding bone rudiments, and as the marrow
cavity develops at E15.5, in osteoclasts in the core of the
diaphysis. In transgenic mice, we observed expression in
periosteal mesenchyme only. Summarizing, we found a
consistent 2-day delay of cartilage and bone development
with all markers investigated.
Proliferation of Chondrocytes and Apoptosis in
Runx2/ and 1(II)-Runt Mice
To investigate whether a decrease in chondrocyte prolif-
eration contributes to the delay in cartilage differentiation
observed, we injected pregnant mice with BrdU and
counted labeled chondrocytes in humeri of E14.5 embryos.
In 1(II)-runt mice, 32.6% (2 SD) were labeled, whereas
controls showed a labeling of 31.7% (1.9 SD). We com-
pared these results with Runx2/ mice (Otto et al., 1997).
We only found a modest reduction in proliferation (46.8%
in wt vs 39.8% in Runx2/). Thus, Runx2 does not seem to
be a major regulator of chondrocyte proliferation. In addi-
tion, we tested for apoptosis in Runx2/ mice in sections
through E14.5 humeri to investigate the possibility that
increased cell death may contribute to the phenotype. We
did not observe any difference between wt and mutant
sections (not shown).
DISCUSSION
Runx2 and Runx3 Are Expressed during Cartilage
Condensation and Differentiation in Partially
Overlapping Domains
Three runx genes are known in vertebrates. Runx1 plays
a pivotal role in hematopoiesis and is associated with the
development of leukemia (Okuda et al., 1996). Runx2 is an
essential factor in skeletogenesis. The function of Runx3 is
largely unknown. Given the identical genomic structure
and the high degree of homology between the runx proteins,
a cooperative function of runx proteins is likely, if they are
expressed at the same sites. We therefore investigated the
expression pattern of Runx3 and compared it to Runx2. The
results show that during early development Runx2 and
Runx3 are differentially expressed. Runx2 expression is
strongly associated with facial development, whereas
Runx3 is specifically expressed in ganglia (Figs. 1A and 1C).
Overlapping expression patterns were observed during skel-
etal development, indicating a possible cooperation/
interaction between both proteins. Both genes showed a
very similar expression pattern in the E13.5 and E14.5
autopod. Both were highly expressed in prechondrocytes of
the perichondrium and in mesenchymal condensations of
the digits. In the growth plate of E14.5 and E15.5 humeri,
however, they show distinct expression patterns with
Runx2 being expressed mainly in hypertrophic chondro-
cytes, whereas Runx3 was expressed in proliferating and
prehypertrophic chondrocytes. Runx2 was highly expressed
in the perichondrium and in osteoblasts. Runx3 was only
weakly expressed in perichondrium, and expression in
osteoblasts was not detectable. We did observe expression
of Runx3 in the bone marrow cavity; however, this may be
due to expression in cells of hematopoietic origin (Fig. 2B).
Normal expression patterns of Runx3 in Runx2/ mice
demonstrated that Runx3 is not regulated by Runx2. The
observed expression patterns suggest a cooperative role of
Runx2 and Runx3 in chondrocyte differentiation and in
cartilage condensation.
Developing Joints and Carpals Are Excluded from
Runx2 and Runx3 Expression
If Runx genes have a significant role in early chondrocyte
differentiation, they should be expressed in early chondro-
cyte condensations and/or chondrocyte precursors. We did
indeed find expression of Runx2 as early as E10.5 in a region
anterior of the limb bud in the future shoulder girdle region
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FIG. 5. Chondrocyte differentiation and bone formation is delayed in 1 (II)-runt transgenic mice. Sections through humeri from wt (left)
and 1 (II)-runt transgenic mice (right) processed for in situ hybridization using 33P-labeled riboprobes specific for Indian hedgehog (Ihh),
collagen type X (Col10), metalloproteinase 13 (MMP13), and metalloproteinase 9 (MMP9) or stained with van Kossa (top panel). The dark
field images are given on the right; the corresponding bright light images are given on the left side. Osteopontin (Osp) expression was
104 Stricker et al.
© 2002 Elsevier Science (USA). All rights reserved.
(Fig. 1B, top panel). This site does not directly correspond to
mesenchymal condensations, but is likely to contain pre-
cursor cells of the developing scapula and clavicula, regions
of the skeleton that are predominantly affected in the
Runx2 heterozygotes (Mundlos et al., 1996). In addition, we
observed expression in cells corresponding to the condensed
humerus and ulna at E 11.5 (Fig. 1B). At E13.5, the digits can
serve as a good model to study condensation and differen-
tiation of chondrocytes. At this stage, the proximal part of
the autopod, the metacarpals, have already differentiated,
while the distal part, the phalanges, are still condensing. At
E13.5, we found strong expression of Runx2 and Runx3 in
the perichondrium of the metacarpals and in the condens-
ing mesenchyme of the distal phalanges (Figs. 1B and 2A).
Both sites generate new chondrocytes that add to the
cartilage anlage by appositional growth. The expression of
Runx2 and Runx3 at these sites correlates with a function
in the regulation of early chondrocyte differentiation. Inter-
estingly, we did not find Runx2 and Runx3 expression in
the carpal bones. Furthermore, a distinct region between
the anlagen representing the future joint space and the
flanking condensations was negative for Runx2 and Runx3
expression (Fig. 2B, bottom panel). Exactly these sites (joint
space, carpal bones) showed extra cartilage formation and
thus the most prominent phenotype in the Runx2 overex-
pression experiments in the chick (as discussed below).
Runx2 Is Not Sufficient for Bone Induction
Skeletal development in the limb begins with the migra-
tion of precursor cells from the lateral plate mesoderm into
the limb bud. At the site of future skeletogenesis epithelial–
mesenchymal interactions result in the formation of a
condensation, a step that is followed by the overt differen-
tiation of chondroblasts or osteoblasts. Runx2 has been
implicated in the latter by the observation that mice with
inactivated Runx2 alleles are devoid of osteoblasts and thus
of bone (Otto et al., 1997; Komori et al., 1997). These and
other more detailed investigations have shown that Runx2
is essential for the differentiation of precursor cells into
osteoblasts. The step at which this block is located remains
elusive but the lack of expression of marker genes for
undifferentiated osteoblasts in Runx2/Cbfa1/ mice indi-
cates a role of Runx2 during early and not during late
differentiation. In agreement with this hypothesis is the
finding that expression of Runx2 can be induced by treating
cells with BMPs, factors that are known as inductors of
bone formation (Ducy et al., 1997; Bae et al., 2001). Fur-
thermore, Runx2 was shown to induce the expression of
osteoblast-specific genes in fibroblasts in vitro (Ducy et al.,
1997). Runx2 may thus be sufficient for osteoblast differen-
tiation from mesenchymal progenitor cells and function as
an inductor for bone formation. However, overexpression of
Runx2 in mice using an osteoblast-specific promotor re-
sults in impaired bone formation and fractures (Lui et al.,
2001).
To evaluate the potential of Runx2 in bone formation in
vivo, we cloned chicken Runx2 and expressed it in limb
buds of chick embryos by using a retroviral system (Morgan
and Fekete, 1996). This system enabled us to express Runx2
in the entire limb bud, thus activating the gene in all cells
that can possibly respond to Runx2. To our surprise, we
neither found any ectopic sites of calcification nor an
alteration in the amount or quality of bone that formed at
its natural site. Affected and unaffected limbs were similar
in respect to their ossification as judged by alizarin red
staining of whole limbs and van Kossa staining of sections.
Thus, Runx2 is not sufficient to induce the differentiation
of mesenchymal cells to bone forming osteoblasts.
Runx2 Overexpression Causes Expansion of
Cartilaginous Elements and Joint Fusions
Instead of inducing osteoblast differentiation, we found
strong alterations in cartilage formation. This was particu-
larly evident in the metacarpals, the carpal bones, and the
joints. In the majority of samples, we observed in HH stage
35 and older embryos a large cartilaginous element located
between the metacarpals and radius/ulna, a space normally
occupied by the radial carpal and several minor carpals.
This carpal element included the radial carpal and extended
toward the ulnar side of the wrist (see Figs. 3A and 3D).
Thus, misexpression of Runx2 resulted in in the expansion/
fusion of smaller cartilaginous elements. These findings
show for the first time in an in vivo system that Runx2
plays an important role in early cartilage differentiation,
probably by directing prechondroblasts toward differentia-
tion along the chondrocyte lineage.
In addition to expansion and fusion of carpal elements,
we found cartilaginous fusion of multiple joints, including
the elbow joint, the radio-carpal joint, the metacarpo-
phalangeal, and the interphalangeal joints. Joint fusions
detected with a digoxygenin-labeled riboprobe. Osteoclasts were visualized with TRAP staining. The developmental stage is indicated on
the left upper corner. Van Kossa stain shows complete lack of black staining in humeri of E15.5 transgenic mice, indicating the absence of
calcified cartilage and bone. In wt mice, Ihh and Col10a1 are expressed in prehypertrophic and hypertrophic chondrocytes, respectively.
They first appear as a single expression domain in the middle of the anlage and then get divided into two domains flanking the newly
developed endochondral bone. In transgenic mice, Col10a1 is not expressed at E14.5 and Ihh still appears as a single domain, indicating a
severe delay in chondrocyte differentiation. Furthermore, terminal differentiation of chondrocytes, as indicated by Osp expression, is not
detectable to a significant extent until E16.5. Expression of MMP13, a proteinase with a role in matrix degradation and invasion, is virtually
absent at E15.5. Formation and invasion of osteoclasts (as indicated by TRAP staining and expression of MMP9) is severly disturbed.
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were also observed by Ueta et al. (2001) in mice that
overexpress Runx2 under the Col2a1 promotor. However,
using a similar experimental design like Ueta et al. (2001)
this phenotype was not observed by Takeda et al. (2001).
The digital rays are thought to be formed from prechondro-
genic condensations that appear spatially continous and
that subsequently segment into individual skeletal ele-
ments. In fact, most of the limb skeleton is thought to arise
by branching and segmentation of preexisting chondrogenic
elements (Shubin and Alberch, 1986). Morphologically,
development of most joints begins with a condensation of
cells at the future joints. In the chick, this so-called inter-
zone develops into a three-layered structure with the cen-
tral region undergoing apoptosis resulting in the formation
of the joint cavity. Recently, a member from the Wnt-
family, Wnt14a, has been implicated in joint induction
(Hartman and Tabin, 2001). Members of the BMP/GDF
families have also been reported to be involved in joint
formation (Francis-West et al., 1999). Among them, Gdf5 is
the most prominent. Overexpression of Runx2, which is
normally not expressed in the joint region (see above),
resulted in the lack of a morphologically defined interzone
and missing Gdf5 expression, indicating that it interacts
with the early events of joint formation. It is therefore
likely that the regression of Runx2 expression is necessary
for proper joint development. Together, the expression data
and the chicken phenotype—lack of ectopic cartilage for-
mation and restriction of the phenotype to sites where
cartilage is present but that are excluded from Runx
expression—indicate a role for Runx genes in the mainte-
nance and not the initiation of the condensation process.
Runx2 therefore seems to direct prechondrogenic cells to
the chondrogenic cell fate and maintains this state. In the
developing joint space of wt animals, this maintenance
factor is turned off, giving way to the transformation of
chondrocytes into joint cells. If expression is maintained at
these sites, the process cannot take place resulting in the
persistence of cartilage. The role of Runx2 in this process
might be in redundancy/cooperation with Runx3 (as dis-
cussed above).
The Size of Long Bones Is Reduced in Runx2-
Infected Chick Limbs
In addition to the carpal and joint phenotype, we observed
a severe reduction in size of the infected chicken limbs.
This was mostly due to shortening of the metacarpals, in
particular metacarpal III, the longest bone in the chick
autopod. Sections of affected metacarpals and in situ hy-
bridization with a probe specific for Ihh revealed a smaller
zone of resting and proliferating chondrocytes, as well as a
reduced prehypertrophic (Ihh-expressing) zone (Fig. 3E). In
endochondral bone formation, a cartilaginous template is
generated first and subsequently replaced by bone. Longi-
tudinal growth takes place by proliferation and differentia-
tion of chondrocytes, the production of cartilaginous ma-
trix, and the replacement of this matrix by bone. To ensure
normal growth, these processes have to be tightly con-
trolled. Several signaling cascades, including BMPs, the
hedgehog pathway, and FGFs, are known to be involved in
this process. Our results indicate that Runx2 plays an
important role in the regulation of differentiation. This
finding is in agreement with overexpression studies in the
mouse that show severe shortening of long bones with
premature formation of hypertrophic chondrocytes (Ueta et
al., 2001; Takeda et al., 2001) and with in vitro studies
showing accelerated differentiation of chondrocytes that
overexpress Runx2 (Enomoto-Iwamoto et al., 2001). Inacti-
vation of Runx2, on the other hand, results in a complete
block of differentiation as demonstrated by the lack of
collagen X (Col10a1) and Ihh expression (Kim et al., 1999;
Inada et al., 1999). Our results confirm that overexpression
of Runx2 in growth plate chondrocytes results in acceler-
ated differentiation which in turn leads to a shortening of
the bones.
A Dominant Negative Form of Runx2 Delays
Endochondral Ossification in Transgenic Mice
To further investigate the role of Runx2 in cartilage
differentiation, we overexpressed a potential dominant
negative form of Runx2 containing only the DNA-binding
domain and the nuclear localization signal (Quack et al.,
2000) but not the N-terminal and C-terminal transactiva-
tion domains. Expressed under the Col2a1 promotor, this
construct is expected to interfere with the function of
cartilage-expressed Runx proteins. Transgenic animals
showed a severely retarded endochondral ossification
caused by a delay in chondrocyte maturation. Proximal
parts of the skeleton were more severely affected than the
distal parts, similar to the Runx2/ mice (Kim et al., 2000).
The delay was apparent from the prehypertrophic zone
onwards, as indicated by the late onset of Ihh expression.
Apparently, Runx2 (and probably Runx3, as discussed
above) functions as a positive regulator of chondrocyte
differentiation. Similar results were reported by Ueta et al.
(2001), who also overexpressed a dominant negative form of
Runx2. However, they observed a stronger lethal phenotype
with a complete block in chondrocyte development before
onset of hypertrophic differentiation. Takeda et al. (2001)
expressed a truncated form of Runx2 containing the
N-terminal part and the DNA-binding domain, but not the
C-terminal transactivation domain. Interestingly, they did
not observe a phenotype when expressing this construct
under a Col2a1 promotor. The phenotypic differences ob-
served might be due to the use of different promotor
constructs. In this study, we use a transgenic line that
shows a distinct phenotype concerning chondrocyte differ-
entiation, but does not exhibit a complete maturational
arrest. Thus, we were able to demonstrate a role for Runx2
as positive regulator of chondrocyte differentiation during
their early but also during late developmental stages, in-
cluding cartilage regression and osteoclast invasion. While
Runx2 has a definite effect on chondrocyte differentiation,
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it seems to have no effect on proliferation, as indicated by
our BrdU-labeling experiments in Runx2/ mice and in the
transgenic 1(II)-runt mice. Thus, the reduction in size is
solely due to a defect in differentiation.
Terminally differentiated chondrocytes are replaced by
bone, a process that involves the removal of matrix by
proteinases together with osteoclasts and the invasion of
blood vessels. Differentiation and invasion of osteoclasts,
on the other hand, require the release of signals from the
matrix, a process where metalloproteinases such as MMP13
are likely to be involved. All of these processes were found
to be severely delayed in 1(II)-runt mice. The low level of
MMP13 expression in hypertrophic chondrocytes is likely
to be a major contributor to this phenotype. MMP13 was
previously shown to be regulated by Runx2 (Hess et al.,
2001). Other metalloproteinases, such as the osteoclast-
derived MMP9, are thought to exert their role in invasion of
the growth plate through the release of molecules seques-
tered in the extracellular matrix (Vu et al., 1998). The
importance of Runx2 in the regulation of invasion is under-
lined by the accelerated invasion in chRunx2 infected chick
bones (Fig. 3F). Similar to desmal ossification, periosteal
bone formation takes place through the differentiation of
precursor cells into osteoblasts. Despite the fact that the
transgene is not expressed in the perichondrium/
periosteum, we observed a delay in periosteal bone forma-
tion in 1(II)-runt mice, indicating that signals from the
differentiated chondrocytes are important for this process.
Ihh is a good candidate to mediate this signal. Ihh expres-
sion is delayed in 1(II)-runt mice and mice with inacti-
vated Ihh alleles lack periosteal bone formation (St-Jaques
et al., 1999).
In summary, our results have shown that Runx2 plays a
pivotal role in early and late chondrocyte differentiation.
While Runx2 is essential for osteoblast differentiation, it is
not sufficient to induce osteoblast differentiation and thus
bone formation in competent cells, indicating that other,
yet unknown factors are needed to induce the differentia-
tion of precursor cells into osteoblasts. Our results indicate
that Runx3 has overlapping functions with Runx2 during
early and late chondrocyte differentiation. It would be
interesting to see whether deletion of both genes will result
in complete loss of chondrocyte differentiation in all skel-
etal elements. The expression of Runx3 in nonhypertrophic
chondrocytes and its presence in Runx2/ mice suggests
that Runx3 functions either upstream of, or in parallel with,
Runx2 in chondrocyte differentiation.
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